» Articles » PMID: 19087323

The Influence of Menstrual Risk Factors on Tumor Characteristics and Survival in Postmenopausal Breast Cancer

Overview
Specialty Oncology
Date 2008 Dec 18
PMID 19087323
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hormonal factors are implicated in tumor progression and it is possible that factors influencing breast cancer induction could affect prognosis. Our study investigated the effects of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer.

Methods: We used a nationwide, population-based, case-case design of 2,640 Swedish women who were 50 to 74 years old and had postmenopausal breast cancer during 1993 to 1995. Follow-up was conducted until 31 December 2000. We used polytomous multiple logistic regression to investigate the relationships between menstrual factors (age at menarche, cycle length, irregular menstruation, lifetime number of menstrual cycles, and age at menopause), tumor characteristics (size, grade, estrogen receptor and progesterone receptor [PR] status, lymph node involvement, and histology), and Cox proportional hazards modeling for 5-year survival.

Results: Younger ages at menarche were significantly associated with grade and lymph node involvement. Women with an age at menarche of 11 years or younger had a more than twofold excess risk of medium-grade (odds ratio [OR] = 2.05; 95% confidence interval [CI] 1.00 to 4.18) and high-grade (OR = 2.04; 95% CI 1.01 to 4.16) tumors. Early menarche significantly increased the risk of lymph node metastases. Survival was poorest in women with the earliest age at menarche, with a 72% increased risk of dying within 5 years after diagnosis (hazard ratio = 1.72; 95% CI 1.02 to 2.89). No significant associations were observed for other menstrual factors with tumor characteristics or survival.

Conclusions: Age at menarche has a significant impact on breast cancer prognosis and survival. It remains to be established whether the associations are attributable to age at menarche directly or are associated with the early-life physiological events of breast development and carcinogenesis also taking place during childhood and puberty, as menarche is only the culmination of this series of events.

Citing Articles

Exploring the handedness-breast cancer nexus: a comprehensive analysis via systematic review, meta-analysis, and Mendelian randomization.

Oh C, Kim E, Kim K, Oh H, Yoon J, Goh T Ther Adv Med Oncol. 2024; 16:17588359241305096.

PMID: 39669193 PMC: 11635856. DOI: 10.1177/17588359241305096.


Locally Advanced Breast Cancer: Response Evaluation to Neoadjuvant Chemotherapy by Clinico-Histopathological Parameters and Molecular Imaging.

Jain A Indian J Surg Oncol. 2023; 14(2):279-287.

PMID: 37324312 PMC: 10267070. DOI: 10.1007/s13193-023-01711-1.


Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women.

Chapadgaonkar S, Bajpai S, Godbole M Cancer Rep (Hoboken). 2023; 6(11):e1847.

PMID: 37311575 PMC: 10644331. DOI: 10.1002/cnr2.1847.


Cross-attention multi-branch CNN using DCE-MRI to classify breast cancer molecular subtypes.

Sun L, Tian H, Ge H, Tian J, Lin Y, Liang C Front Oncol. 2023; 13:1107850.

PMID: 36959806 PMC: 10028183. DOI: 10.3389/fonc.2023.1107850.


Breast cancer relapses considering molecular biological characteristics.

Smolanka I, Movchan O, Bagmut I, Sheremet M, Kolisnyk I, Dosenko I J Med Life. 2023; 16(1):70-75.

PMID: 36873133 PMC: 9979183. DOI: 10.25122/jml-2022-0189.


References
1.
Apter D . Hormonal events during female puberty in relation to breast cancer risk. Eur J Cancer Prev. 1996; 5(6):476-82. View

2.
Key T, Pike M . The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988; 24(1):29-43. DOI: 10.1016/0277-5379(88)90173-3. View

3.
Caleffi M, Fentiman I, Birkhead B . Factors at presentation influencing the prognosis in breast cancer. Eur J Cancer Clin Oncol. 1989; 25(1):51-6. DOI: 10.1016/0277-5379(89)90050-3. View

4.
Korzeniowski S, Dyba T . Reproductive history and prognosis in patients with operable breast cancer. Cancer. 1994; 74(5):1591-4. DOI: 10.1002/1097-0142(19940901)74:5<1591::aid-cncr2820740515>3.0.co;2-#. View

5.
Vandeloo M, Bruckers L, Janssens J . Effects of lifestyle on the onset of puberty as determinant for breast cancer. Eur J Cancer Prev. 2007; 16(1):17-25. DOI: 10.1097/01.cej.0000220635.38847.6e. View